Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag

Oncology August 03,2024 0

Computational tool integrates transcriptomic data to enhance breast cancer diagnosis and treatment

by Nik Papageorgiou,Ecole Polytechnique Federale de LausanneClinical validation of EMBER. Credit:npj Breast Cancer(2024). DOI: 10.1038/s41523-024-00665-zAddressing problems with diag

Oncology August 03,2024 0

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Oncology August 03,2024 0

Ophthalmologic manifestations of acute leukemia are heterogeneous

by Elana GotkineOphthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a studypublishedonline July 10 in the&nbsp

Oncology August 03,2024 0

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10

Oncology August 03,2024 0

AI model identifies certain breast tumor stages likely to progress to invasive cancer

by Adam ZeweA large-scale high-resolution chromatin imaging dataset enables the analysis of disease stages and phenotypic categories in DCIS. Credit:Nature Communications(2024). DOI: 10.10

Oncology August 03,2024 0

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Oncology August 03,2024 0

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Oncology August 03,2024 0

Researchers learn how cancer cells divide despite treatment

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineResearchers first saw evidence that some cells were escaping arrest in the continued presence of Palbociclib just

Oncology August 03,2024 0

Researchers learn how cancer cells divide despite treatment

by Kendall Daniels,University of North Carolina at Chapel Hill School of MedicineResearchers first saw evidence that some cells were escaping arrest in the continued presence of Palbociclib just

Oncology August 03,2024 0

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal

Oncology August 03,2024 0

Research points the way toward an exhaled-breath test for lung cancer

by Hackensack Meridian HealthOlivier Loudig, Ph.D., of the Hackensack Meridian Center for Discovery and Innovation (CDI). Credit: Hackensack Meridian HealthThe foundational science to develop an exhal

Oncology August 03,2024 0

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita

Oncology August 03,2024 0

Findings reveal unexpected role of protein OTX2 that drives aggressive medulloblastoma

byBaylor College of MedicineCredit: Unsplash/CC0 Public DomainIn a reportpublishedinNature Cell Biology, researchers at Baylor College of Medicine, Texas Children's Hospita

Oncology August 03,2024 0

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Oncology August 03,2024 0

And improved method for anti-cancer drug detection: How tiny tumor models could transform drug testing

by Songshan Lake Materials LaboratorySchematic of microfluidic chip-based approach for quality assessment and screening of esophageal cancer drugs. A three-dimensional scaffold with inverse opal struc

Oncology August 03,2024 0

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Oncology August 03,2024 0

Preclinical study shows promise of systemic targeted therapy in a rare form of cancer

byVall d'Hebron Institute of OncologyTreatment with BRAF inhibitors reduces tumor cell proliferation in subcutaneous BRAFV600EPMP-PDX tumors without impacting in apoptosis. a–d) Mice b

Oncology August 03,2024 0

Study shows elevated cancer risk for women with endometriosis

byHuntsman Cancer InstituteCredit: CC0 Public DomainA landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at

Oncology August 03,2024 0

Study shows elevated cancer risk for women with endometriosis

byHuntsman Cancer InstituteCredit: CC0 Public DomainA landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at

Oncology August 03,2024 0